Anti-ROR1 antibodies
US11155615B2 · kind B2 · utility
7Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 17, 2016 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Aug 17, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/912
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibodies, and in particular, to antibodies exhibiting specificity for Receptor tyrosine kinase-like Orphan Receptors (ROR), and to uses thereof, for example in the treatment of cancer. The invention extends to polynucleotide and polypeptide sequences encoding the antibodies, and therapeutic uses thereof, and to diagnostic kits comprising these molecules. The invention also extends to antibody-drug conjugates and to uses thereof in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.